These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19443805)

  • 21. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice.
    Link JM; Rich CM; Korat M; Burrows GG; Offner H; Vandenbark AA
    Clin Immunol; 2007 Apr; 123(1):95-104. PubMed ID: 17257899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke.
    Chen C; Jiang W; Liu Z; Li F; Yang J; Zhao Y; Ran Y; Meng Y; Ji X; Geng X; Du H; Hu X
    J Neuroinflammation; 2018 May; 15(1):167. PubMed ID: 29807548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury.
    Yang L; Liu Z; Ren H; Zhang L; Gao S; Ren L; Chai Z; Meza-Romero R; Benedek G; Vandenbark AA; Offner H; Li M
    Metab Brain Dis; 2017 Oct; 32(5):1395-1402. PubMed ID: 28303450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
    Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
    J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice.
    Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
    Metab Brain Dis; 2014 Mar; 29(1):59-73. PubMed ID: 24374817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
    Frenkel D; Huang Z; Maron R; Koldzic DN; Hancock WW; Moskowitz MA; Weiner HL
    J Immunol; 2003 Dec; 171(12):6549-55. PubMed ID: 14662856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
    Sinha S; Miller L; Subramanian S; McCarty OJ; Proctor T; Meza-Romero R; Huan J; Burrows GG; Vandenbark AA; Offner H
    J Neuroimmunol; 2010 Aug; 225(1-2):52-61. PubMed ID: 20546940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ICAM-1
    Enzmann GU; Pavlidou S; Vaas M; Klohs J; Engelhardt B
    Transl Stroke Res; 2018 Dec; 9(6):608-621. PubMed ID: 29399739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RTL therapy for multiple sclerosis: a Phase I clinical study.
    Offner H; Sinha S; Burrows GG; Ferro AJ; Vandenbark AA
    J Neuroimmunol; 2011 Feb; 231(1-2):7-14. PubMed ID: 20965577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha).
    Qazi MR; Xia Z; Bogdanska J; Chang SC; Ehresman DJ; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Toxicology; 2009 Jun; 260(1-3):68-76. PubMed ID: 19464571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination stroke therapy in the mouse with blood-brain barrier penetrating IgG-GDNF and IgG-TNF decoy receptor fusion proteins.
    Sumbria RK; Boado RJ; Pardridge WM
    Brain Res; 2013 Apr; 1507():91-6. PubMed ID: 23428543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis.
    Huan J; Kaler LJ; Mooney JL; Subramanian S; Hopke C; Vandenbark AA; Rosloniec EF; Burrows GG; Offner H
    J Immunol; 2008 Jan; 180(2):1249-57. PubMed ID: 18178865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
    Poittevin M; Deroide N; Azibani F; Delcayre C; Giannesini C; Levy BI; Pocard M; Kubis N
    J Neuroimmunol; 2013 Jan; 254(1-2):55-62. PubMed ID: 23026222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke.
    Zhang B; Subramanian S; Dziennis S; Jia J; Uchida M; Akiyoshi K; Migliati E; Lewis AD; Vandenbark AA; Offner H; Hurn PD
    J Immunol; 2010 Apr; 184(8):4087-94. PubMed ID: 20304826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation.
    Bodhankar S; Chen Y; Lapato A; Dotson AL; Wang J; Vandenbark AA; Saugstad JA; Offner H
    Stroke; 2015 Oct; 46(10):2926-34. PubMed ID: 26306753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous IFN-β signaling exerts anti-inflammatory actions in experimentally induced focal cerebral ischemia.
    Inácio AR; Liu Y; Clausen BH; Svensson M; Kucharz K; Yang Y; Stankovich T; Khorooshi R; Lambertsen KL; Issazadeh-Navikas S; Deierborg T
    J Neuroinflammation; 2015 Nov; 12():211. PubMed ID: 26581581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke.
    Shibata M; Kumar SR; Amar A; Fernandez JA; Hofman F; Griffin JH; Zlokovic BV
    Circulation; 2001 Apr; 103(13):1799-805. PubMed ID: 11282913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice.
    Sheu JR; Chen ZC; Jayakumar T; Chou DS; Yen TL; Lee HN; Pan SH; Hsia CH; Yang CH; Hsieh CY
    Sci Rep; 2017 Feb; 7():42277. PubMed ID: 28165057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.